3.3. Increasing Concentrations of Humanized Anti-MUC1 Antibodies Enhance NK Cell Activation and Induce CD16 Down-Regulation, but Do Not Further Enhance Tumor Cell Killing. Here, FCGR3A is linked to neoplasm.